SEC Form 4 · accession 0001716950-18-000019
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Feinsod
Officer — Interim Chief Medical Officer
Period of report
Jun 11, 2018
Accepted (ET)
Jun 13, 2018 · 7:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 11, 2018 | A | 2,000 | $0.00 | A | 39,267 | D | |
| Common Stock | Jun 11, 2018 | F | 606 | $4.55 | D | 38,661 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The common stock vested immediately upon grant.